Original articlePopulation-Based Incidence of Uveal Melanoma in Various Races and Ethnic Groups
Section snippets
Material and methods
Ocular melanoma incidence rates were obtained from population-based data that were collected by the SEER Program of the National Cancer Institute, which were released in April 2002 and based on a November 2001 submission. Data consisted of cancer cases that were reported on different races and were diagnosed from 1992 to 2000 among residents of 11 geographic areas, which included Atlanta, Georgia; Connecticut; Detroit, Michigan; Hawaii; Iowa; New Mexico; San Francisco-Oakland, California;
Results
Table 1 shows age-adjusted incidence rates and rate ratios for uveal melanoma by racial/ethnic groups in 11 SEER registries from 1992 to 2000. Ninety-five percent of patients were non-Hispanic white; 3.8% were Hispanic; 0.7% were Asian/Pacific Islander, and 0.7% were black. No cases of uveal melanoma were reported in the American Indian group. The age-adjusted incidence of uveal melanoma ranged from 0.31 to 6.37 per 100,000 in the different racial/ethnic groups. When compared with the black
Discussion
Uveal malignant melanoma is relatively rare in the black population. In 1962, Hogan and Zimmerman5 reported that the ratio of uveal melanoma in white vs non-white groups was 250:1. Paul, Parnell and Franker4 reviewed all of the intraocular melanoma cases at the Armed Forces Institute of Pathology from 1930 to 1961 and found only 24 cases of malignant melanoma in the black patients. They estimated the ratio of uveal melanoma in the black:white population to be 1:165. In 1983, Shields and Shields
Dan-Ning Hu, MD, graduated from the Shanghai First Medical College and was a fellow at the Wilmer Ophthalmological Institute. He has been the Director of Tissue Culture Center at the New York Eye and Ear Infirmary and Professor of Ophthalmology, New York Medical College since 1990. His main interests are cell culture, cell transplantation, pigment cell research, ophthalmic genetics, and myopia. He has published 341 papers and contributed to the publication of 16 books.
References (35)
- et al.
Epidemiologic aspects of uveal melanoma
Surv Ophthalmol
(1988) - et al.
Incidence of surgically treated uveal melanoma by race and ethnicity
Ophthalmology
(1998) - et al.
Incidence of uveal melanoma in the United States1973–1997
Ophthalmology
(2003) - et al.
Increased incidence of choroidal malignant melanoma occurring in a single population of chemical workers
Am J Ophthalmol
(1980) - et al.
Ocular Melanoma Task Force report
Am J Ophthalmol
(1980) - et al.
Conjunctival melanoma in the black population
Surv Ophthalmol
(1998) - et al.
Conjunctival melanomais it increasing in the United States?
Am J Ophthalmol
(2003) - et al.
The epidemiology of ophthalmic malignancies in New York State
Ophthalmology
(1990) - et al.
Uveal melanomas in black patientsa case series and comparative review
J Natl Med Assoc
(1995) - et al.
Malignant melanoma of the choroid and ciliary body in black patients
Arch Ophthalmol
(1984)
Prognosis of malignant melanomas of the choroid and ciliary body
Int J Ophthalmic Clinic
Ophthalmic pathologyan atlas and textbook
Ocular malignant melanoma in South African blacks
Br J Ophthalmol
Ocular pathologya text and atlas
Uveal melanoma
Trends in incidence of ocular malignant melanoma in Denmark 1943-1982
Int J Cancer
Incidence of uveal melanoma in Sweden from 1960 to 1980
Invest Ophthalmol Vis Sci
Cited by (0)
Dan-Ning Hu, MD, graduated from the Shanghai First Medical College and was a fellow at the Wilmer Ophthalmological Institute. He has been the Director of Tissue Culture Center at the New York Eye and Ear Infirmary and Professor of Ophthalmology, New York Medical College since 1990. His main interests are cell culture, cell transplantation, pigment cell research, ophthalmic genetics, and myopia. He has published 341 papers and contributed to the publication of 16 books.
Guo-Pei Yu, MD, MPH, currently serves as Chief Epidemiologist and Biostatistician of New York Eye and Ear Infirmary. His main interests are to study the etiology and prevention of various diseases and to evaluate therapeutic effectiveness. He graduated from Shanghai First Medical College where he was a Professor of Epidemiology. Dr. Yu was a research fellow in Harvard School of Public Health.
Supported by the New York Eye and Ear Infirmary Pathology Research Fund, the Department of Ophthalmology Research Fund (design and conduct of the study and preparation of the manuscript), and The EyeCare Foundation (review of the manuscript).